Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Response to (K)RASG12C and EGFR Inhibition in a Patient With NRASG12C-Mutated Rectal Cancer.

JCO precision oncology - 1 May 2023

Möhrmann Lino, Cuberi Ani, Brückmann Sascha, Stasik Sebastian, Heukamp Lukas C, Bornhäuser Martin, Glimm Hanno, Folprecht Gunnar

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ErbB Receptors
Share to GTP Phosphohydrolases
Share to Membrane Proteins
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Rectal Neoplasms

Source

Identifiers

PMID: 37262393
DOI: 10.1200/PO.22.00666

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Response to (K)RASG12C and EGFR Inhibition in a Patient With NRASG12C-Mutated Rectal Cancer.PMID 37262393Read ↗

Progress of KRAS G12C inhibitors in the treatment of refractory colorectal cancer and strategies for drug resistance response.Semantic proximity Read ↗

ASO Author Reflections: Impact of RAS Mutations on Total Neoadjuvant Therapy Outcomes in Rectal Cancer.Semantic proximity Read ↗

HRAS G13D, a new mutation implicated in the resistance to anti-EGFR therapies in colorectal cancer, a case report.Semantic proximity Read ↗

Impact of RAS/BRAF mutation status in locally advanced rectal cancer treated with preoperative chemotherapy.Semantic proximity Read ↗

Association Between RAS/BRAF Mutations and Complete Response Following Total Neoadjuvant Therapy in Patients with Rectal Cancer: A Prospective Multicentered Study.Semantic proximity Read ↗

Gene expression profile is associated with chemoradiation resistance in rectal cancerSemantic proximity Read ↗

Epithelial mesenchymal transition and resistance to neoadjuvant radiotherapy in locally advanced rectal cancerSemantic proximity Read ↗

[K-ras mutations in rectal cancer undergone preoperative radiotherapy].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.